Patient-Centric Formulations: Strategies for Differentiated Oral Drugs, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers from Lubrizol Life Science Health will discuss the challenges for patients with oral drug formulations, including the swallowability of tablets, the inconvenience of multiple doses and liquid-specific challenges such as bitter taste and difficult administration. Attendees will learn about strategies for overcoming patient-centric challenges to successfully differentiate oral drug products, including extended drug release, table size reduction, taste masking and mucoadhesion, among others.

This webinar will discuss some key challenges of oral drug formulations, including the swallowability of tablets, bitter taste and the inconvenience of multiple doses.

While advancements in drug delivery are continually improving drug efficacy and bioavailability, there is still a significant unmet need in terms of developing formulations that make patients’ lives easier. Patient-centricity is not only about best supporting the end user – it’s also about differentiating your product in a sea of oral drug formulations, particularly when looking to file a generic or 505(b)(2) application.

This webinar will discuss some key challenges of oral drug formulations, including the swallowability of tablets, bitter taste and the inconvenience of multiple doses. The team at Lubrizol Life Science Health (LLS Health) will then uncover strategies for overcoming these challenges which will also help differentiate your product, such as with extended drug release, taste masking and tablet size reduction.

Join Gaurab Sengupta, Global Business Manager - Pharmaceutical Excipients, LLS Health and Rajib Bhattacharjee, Global Market Manager - Oral Treatments, LLS Health in a live webinar on Thursday, October 29, 2020 at 9am EDT (1pm GMT/UK).

For more information or to register for this event, visit Patient-Centric Formulations: Strategies for Differentiated Oral Drugs.

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway Company, leverages its unmatched science to unlock immense possibilities at the molecular level, driving sustainable and measurable results to help the world Move Cleaner, Create Smarter and Live Better. Founded in 1928, Lubrizol owns and operates more than 100 manufacturing facilities, sales and technical offices around the world and has approximately 8,800 employees. For more information, visit http://www.Lubrizol.com.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website